Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Gilead

Gilead success in late-stage hepatitis B trials

January 5, 2016 Research and Development, Sales and Marketing Gilead, hepatitis B, phase III

Two Phase III trials evaluating Gilead treatments in chronic hepatitis B virus (HBV) infection have met their primary objectives, showing …
News
Lilly building

Eli Lilly predicts revenue growth in 2016

January 5, 2016 Research and Development, Sales and Marketing Eli Lilly, financial reports, marketing, sales

Eli Lilly has set out its financial guidance for 2016, predicting an increase in sales to between $20.2 and $20.7 …
News
david_pyott

BioMarin elects former Allergan CEO to board

January 5, 2016 Medical Communications, Research and Development, Sales and Marketing

BioMarin Pharmaceutical has announced the election of former Allergan chief executive, David Pyott, to the company’s board of directors. Pyott served …
Appointment
Actelion logo

Actelion’s Uptravi goes on sale

January 5, 2016 Manufacturing and Production, Sales and Marketing Actelion, PAH, Uptravi, pulmonary arterial hypertension, pulmonary hypertension, selexipag

Swiss pharma firm Actelion has put its new drug for pulmonary hypertension, Uptravi, up for sale in the US, weeks …
News
Baxalta logo

Bayer and Baxalta in separate €1 billion-plus deals

January 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ascensia diabetes care, Baxalta, Bayer, diabetes, panasonic, symphogen

Baxalta has signed a deal with Symphogen potentially worth as much as €1.4 billion, under which the companies will develop …
News
erbitux-resized

Merck’s Erbitux approved for NHS Wales

January 5, 2016 Manufacturing and Production, Sales and Marketing Erbitux, Merck, cetuximab, colorectal cancer, metastatic colorectal cancer

The All Wales Medicines Strategy Group has recommended Merck’s Erbitux in combination with chemotherapy for restricted use in the NHS …
News
AS spine fusion

Novartis’ Cosentyx shows benefits in Phase III AS trials

January 4, 2016 Research and Development, Sales and Marketing Cosentyx, Novartis, Secukinumab, ankylosing spondylitis

Novartis says results from two Phase III studies for Cosentyx in ankylosing spondylitis (AS) showing significant clinical improvements versus placebo.Results …
News
redx

Former Merck R&D expert joins RedX Pharma board

January 4, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RedX Pharma

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …
Appointment
Logos

Reports: $32bn Shire takeover of Baxalta close to done deal

January 4, 2016 Sales and Marketing Baxalta, Shire, acquisition, merger

The deal may have failed to get over the line in 2015, but reports suggest the mega merger is to …
News
pharma manufacturing

‘Rejuvenated’ pharma manufacturing set for 2016 comeback

January 4, 2016 Manufacturing and Production, Sales and Marketing Employment, industry, manufacturing, patent cliff, pharma, production

The pharma industry has been singled out for its strong performance in 2015, in a report which says manufacturing in …
News

Takeda and Teva set out generics joint venture plan

January 4, 2016 Sales and Marketing Takeda, Teva, generics, joint venture

Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …
News
NASDAQ

KaloBios files for bankruptcy after Shkreli arrest

January 4, 2016 Sales and Marketing KaloBios, Martin Shkreli

KaloBios has filed for bankruptcy in the wake of chief executive Martin Shkreli’s arrest on securities fraud charges last month …
News
Gavel

J&J and Purdue settle Kentucky lawsuits for $39.5 million

December 24, 2015 Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits

Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …
News
Dr Andreas Barner

Boehringer Ingelheim invests in Europe

December 24, 2015 Manufacturing and Production, Sales and Marketing Austria, Biberach, Boehringer Ingelheim, Vienna, biologicals, manufacturing, production

Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …
News
Pills image

OTC drugs market boosted by growing patient demand

December 24, 2015 Manufacturing and Production, Sales and Marketing GBI Research, OTC, generics, over the counter

Increasing pressures from customers, drug manufacturers and regulators to convert prescription medications to over-the-counter (OTC) non-prescription status is driving growth …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026